Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Patron Partners LLC

Patron Partners LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.9% in the second quarter, Holdings Channel reports. The fund owned 1,845 shares of the medical equipment provider’s stock after buying an additional 69 shares during the period. Patron Partners LLC’s holdings in Intuitive Surgical were worth $821,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of the business. Creekmur Asset Management LLC grew its holdings in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares during the period. Ridgewood Investments LLC acquired a new position in Intuitive Surgical in the 2nd quarter valued at about $26,000. Able Wealth Management LLC acquired a new position in Intuitive Surgical in the 4th quarter valued at about $28,000. Delos Wealth Advisors LLC grew its stake in shares of Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares during the period. Finally, LRI Investments LLC acquired a new stake in shares of Intuitive Surgical during the 1st quarter worth approximately $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Down 1.0 %

NASDAQ:ISRG opened at $471.82 on Friday. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $493.97. The firm has a market cap of $167.35 billion, a PE ratio of 85.17, a price-to-earnings-growth ratio of 5.43 and a beta of 1.39. The stock has a fifty day moving average price of $458.74 and a 200 day moving average price of $417.98.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The company had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. During the same quarter last year, the company earned $1.18 EPS. Intuitive Surgical’s revenue for the quarter was up 14.5% compared to the same quarter last year. Equities analysts forecast that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 239 shares of the stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $416.60, for a total value of $99,567.40. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,293,799.60. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Intuitive Surgical news, EVP Robert Desantis sold 239 shares of Intuitive Surgical stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $416.60, for a total transaction of $99,567.40. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,293,799.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Henry L. Charlton sold 40,243 shares of the company’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at $1,461,006.84. The disclosure for this sale can be found here. Insiders sold 51,656 shares of company stock worth $24,700,644 over the last 90 days. 0.90% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several analyst reports. BTIG Research increased their price objective on Intuitive Surgical from $469.00 to $494.00 and gave the stock a “buy” rating in a research report on Wednesday, August 28th. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and increased their price target for the stock from $380.00 to $510.00 in a report on Friday, August 2nd. Piper Sandler boosted their price objective on shares of Intuitive Surgical from $490.00 to $495.00 and gave the company an “overweight” rating in a report on Friday, July 19th. Robert W. Baird increased their target price on shares of Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a research note on Friday, July 19th. Finally, Evercore ISI dropped their price target on shares of Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating for the company in a research report on Friday, July 19th. Six equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $446.45.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.